Author:
Aiyegbo Mohammed S.,Shmelkov Evgeny,Dominguez Lorenzo,Goger Michael,Battacharya Shibani,deCamp Allan C.,Gilbert Peter B.,Berman Phillip W.,Cardozo Timothy
Funder
National Institutes of Health
NYSTAR and ORIP/NIH
Henry Jackson Foundation
The Keck Foundation
New York State Assembly
U.S. Department of Defense
Publisher
Public Library of Science (PLoS)
Reference31 articles.
1. Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines;JL Excler;Clin Vaccine Immunol,2014
2. Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection;NM Flynn;Journal of Infectious Diseases,2005
3. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand;P Pitisuttithum;J Infect Dis,2006
4. Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study;GE Gray;Lancet Infect Dis,2011
5. HIV vaccines: lessons learned and the way forward;JH Kim;Curr Opin HIV AIDS,2010
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献